Across TCGA pan-cancer cohorts, CFAP43 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CFAP43 data layer compared with 23 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CFAP43 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP43 expression acts as an unfavorable survival marker.
UCEC are the cancer types where CFAP43 mass-spec protein most reproducibly stratifies survival.